FN2 Earnings Intelligence
DexCom, Inc. financials
DexCom, Inc. (DXCM) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,052.6 | $642.3 | $566.3 | $606.1 | $917.7 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $2,448.5 | $2,909.8 | $3,622.3 | $4,033 | $4,662 | $5,223.3 | $5,817.2 |
| % Growth | 27.1% | 18.8% | 24.5% | 11.3% | 15.6% | 12.0% | 11.4% |
| Gross Profit | $1,680.5 | $1,883.1 | $2,288.9 | $2,438.2 | $2,801.9 | - | - |
| % Margin | 68.6% | 64.7% | 63.2% | 60.5% | 60.1% | - | - |
| EBITDA | $367.8 | $547.1 | $783.7 | $817.7 | $1,163.6 | - | - |
| % Margin | 15.0% | 18.8% | 21.6% | 20.3% | 25.0% | - | - |
| Net Income | $154.7 | $341.2 | $541.5 | $576.2 | $836.3 | - | - |
| % Margin | 6.3% | 11.7% | 14.9% | 14.3% | 17.9% | - | - |
| Diluted EPS | $1.55 | $0.82 | $1.30 | $1.42 | $2.09 | $2.59 | $3.09 |
| % Growth | -69.4% | -47.1% | 58.5% | 9.2% | 47.2% | 24.1% | 19.2% |
| Operating Cash Flow | $442.5 | $669.5 | $748.5 | $989.5 | $1,440.7 | - | - |
| CapEx | $389.2 | $364.8 | $236.6 | $358.8 | $363.5 | - | - |
| Free Cash Flow | $53.3 | $304.7 | $511.9 | $630.7 | $1,077.2 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $2,448.5 | $2,909.8 | $3,622.3 | $4,033 | $4,662 | $5,223.3 | $5,817.2 |
| Gross Profit | $1,680.5 | $1,883.1 | $2,288.9 | $2,438.2 | $2,801.9 | - | - |
| EBITDA | $367.8 | $547.1 | $783.7 | $817.7 | $1,163.6 | - | - |
| Net Income | $154.7 | $341.2 | $541.5 | $576.2 | $836.3 | - | - |
| Diluted EPS | $1.55 | $0.82 | $1.30 | $1.42 | $2.09 | $2.59 | $3.09 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,052.6 | $642.3 | $566.3 | $606.1 | $917.7 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $442.5 | $669.5 | $748.5 | $989.5 | $1,440.7 |
| Capital Expenditure | $389.2 | $364.8 | $236.6 | $358.8 | $363.5 |
| Free Cash Flow | $53.3 | $304.7 | $511.9 | $630.7 | $1,077.2 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 27.1% | 18.8% | 24.5% | 11.3% | 15.6% |
| Gross Margin | 68.6% | 64.7% | 63.2% | 60.5% | 60.1% |
| EBITDA Margin | 15.0% | 18.8% | 21.6% | 20.3% | 25.0% |
| Net Margin | 6.3% | 11.7% | 14.9% | 14.3% | 17.9% |
| FCF Margin | 2.2% | 10.5% | 14.1% | 15.6% | 23.1% |
| Diluted EPS Growth | -69.4% | -47.1% | 58.5% | 9.2% | 47.2% |